35242765 34228644 35053377 33572835 34297308 35855914 34305530 34484197 33864561 34638471 33837065 35267432 33239433 35340676 35582442 34097097 34041034 35711434 33800301 34988450 34615656 35806212 34203660 35806051 34113233 33224149 33419531 3343520 - Search Results

Year	Number of Results
2020	6
2021	33
2022	27

1

Proteolysis-Targeting Chimera (PROTAC): Is the Technology Looking at the Treatment of Brain Tumors?

Lospinoso Severini L, Bufalieri F, Infante P, Di Marcotullio L. Lospinoso Severini L, et al. Front Cell Dev Biol. 2022 Feb 15;10:854352. doi: 10.3389/fcell.2022.854352. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35242765 Free PMC article. Review.

2

Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma.

Chen A, Jiang Y, Li Z, Wu L, Santiago U, Zou H, Cai C, Sharma V, Guan Y, McCarl LH, Ma J, Wu YL, Michel J, Shi Y, Konnikova L, Amankulor NM, Zinn PO, Kohanbash G, Agnihotri S, Lu S, Lu X, Sun D, Gittes GK, Wang Q, Xiao X, Yimlamai D, Pollack IF, Camacho CJ, Hu B. Chen A, et al. J Clin Invest. 2021 Aug 16;131(16):e147552. doi: 10.1172/JCI147552. J Clin Invest. 2021. PMID: 34228644 Free PMC article.

3

Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma.

Persico M, Abbruzzese C, Matteoni S, Matarrese P, Campana AM, Villani V, Pace A, Paggi MG. Persico M, et al. Cells. 2022 Jan 13;11(2):263. doi: 10.3390/cells11020263. Cells. 2022. PMID: 35053377 Free PMC article. Review.

4

Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development.

Majc B, Novak M, Kopitar-Jerala N, Jewett A, Breznik B. Majc B, et al. Cells. 2021 Jan 29;10(2):265. doi: 10.3390/cells10020265. Cells. 2021. PMID: 33572835 Free PMC article. Review.

5

Emerging Technologies for Non-invasive Monitoring of Treatment Response to Immunotherapy for Brain Tumors.

Mathios D, Srivastava S, Kim T, Bettegowda C, Lim M. Mathios D, et al. Neuromolecular Med. 2022 Jun;24(2):74-87. doi: 10.1007/s12017-021-08677-9. Epub 2021 Jul 23. Neuromolecular Med. 2022. PMID: 34297308 Review.

6

Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development.

Wu C, Qin C, Long W, Wang X, Xiao K, Liu Q. Wu C, et al. J Big Data. 2022;9(1):92. doi: 10.1186/s40537-022-00643-x. Epub 2022 Jul 14. J Big Data. 2022. PMID: 35855914 Free PMC article.

7

Harnessing the Activation of RIG-I Like Receptors to Inhibit Glioblastoma Tumorigenesis.

Bufalieri F, Basili I, Di Marcotullio L, Infante P. Bufalieri F, et al. Front Mol Neurosci. 2021 Jul 8;14:710171. doi: 10.3389/fnmol.2021.710171. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34305530 Free PMC article.

8

Roles of Neutrophils in Glioma and Brain Metastases.

Lin YJ, Wei KC, Chen PY, Lim M, Hwang TL. Lin YJ, et al. Front Immunol. 2021 Aug 13;12:701383. doi: 10.3389/fimmu.2021.701383. eCollection 2021. Front Immunol. 2021. PMID: 34484197 Free PMC article. Review.

9

Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas.

Cho YA, Kim D, Lee B, Shim JH, Suh YL. Cho YA, et al. J Neurooncol. 2021 May;153(1):43-53. doi: 10.1007/s11060-021-03710-0. Epub 2021 Apr 17. J Neurooncol. 2021. PMID: 33864561

10

Challenges and Prospects for Designer T and NK Cells in Glioblastoma Immunotherapy.

Arnesen VS, Gras Navarro A, Chekenya M. Arnesen VS, et al. Cancers (Basel). 2021 Oct 5;13(19):4986. doi: 10.3390/cancers13194986. Cancers (Basel). 2021. PMID: 34638471 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results